META After Q3 Earnings: Street Holds the Bull Case, Stock Seeks a Floor

The positioning picture remains structurally unthreatening to the downside — but short sellers are quietly building. Short interest has climbed 9% in share terms on the week and 16.5% on the month, reaching 1.74% of the free float. That is the fastest monthly accumulation in recent history for a stock of this size, and it is a change from the prior week's narrative of thin, directionless short positioning. Even so, the absolute level stays low enough that there is no squeeze pressure, no crowding, and no signal of a coordinated bear thesis. The borrow market is effectively frictionless: availability is uncapped, with over two billion shares in the lending pool, and cost to borrow has actually eased sharply — falling 35% on the week to 0.15%, the lowest in the 30-day history. Options confirm the same read. The put/call ratio of 0.46 sits barely above its 20-day average of 0.45, and the z-score of 0.77 reflects no meaningful shift toward defensive hedging despite the stock's decline. Positioning looks incrementally cautious but nowhere near alarmed.

The Street's response to the Q3 result has been to hold the constructive line with modest recalibration. Guggenheim reiterated its Buy at $800 the morning after the print. Raymond James and Wells Fargo both raised targets last week — to $850 and $835 respectively — ahead of the report itself, underscoring that the sell side went into Q3 with conviction and has not publicly walked it back. The mean analyst target of $825 implies 39% upside to the current price, the widest gap since this series of notes began tracking the stock. That gap reflects two simultaneous moves: the Street marked up its view on AI monetization potential, while the stock erased those gains. Bulls cite the Meta Model API, Muse Spark, and sustained ad targeting improvements as durable growth levers. Bears point to regulatory exposure, dependence on ad-monetization revenue, and the compounding weight of capital expenditure that is growing faster than consensus had modeled. The EPS momentum scores remain solid — 71 on a 30-day basis and 73 on 90 days — and the EPS surprise rank at 78 reflects a history of beating estimates. The drag is valuation: a PE of 17x and EV/EBITDA of 9.1x sound undemanding in isolation, but the ORTEX value factor score of 34 reflects how stretched the name remains relative to the broader universe when earnings growth is already well-discounted.

Institutional positioning offers no obvious read-through. BlackRock added roughly 2.2 million shares through June, Capital Research added 6.7 million, and JPMorgan Asset Management added 4 million — all incremental accumulation rather than conviction-sized moves. COO Javier Olivan sold approximately $950,000 in shares on July 20 across several tranches, consistent with a pre-arranged plan at elevated prices near $646; those sales were executed well above today's level. The 90-day insider net is marginally positive in share terms, though overwhelmingly driven by plan-based selling at prices the stock has since retreated from.

What to watch next is whether the Q3 result and guidance — delivered July 29 — produce the same pattern of day-one selling followed by continued drift, or whether the Street's uniform refusal to downgrade translates into buying interest as the gap to consensus targets widens past 39%.